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Detection of Undiagnosed HIV
Among State Prison Entrants
A substantial proportion of individuals infected with the hu-
man immunodeficiency virus (HIV) in the United States en-
ter a correctional facility annually.1,2 Therefore, incarceration
presents an opportunity for HIV detection. Even though many
states have adopted policies of mass HIV screening of
inmates,2-4 the extent to which HIV testing on prison entry de-
tects new infections is unclear.
WeexaminedHIVprevalenceamonginmatesenteringastate
prison system and the proportion known to state public health
authorities as having previously tested HIV seropositive.
Methods | We evaluated individuals entering the North Caro-
lina Department of Public Safety (NC DPS) between June 2008
and April 2009. Testing entering inmates for HIV in North Caro-
lina was voluntary; however, a state statute mandated screen-
ing for syphilis. Excess blood was batch tested for HIV anti-
bodies (Labcorp Inc). Before removing links to the inmate’s HIV
test result, identifiers were used to merge prison test results
with the North Carolina Department of Health and Human Ser-
vices (NC DHHS) HIV testing database. The University of North
Carolina biomedical institutional review board, the NC DPS hu-
man subjects review committee, and the US Office of Human
Research Protections approved the study. A waiver of in-
formed consent was provided.
Results | During the study period, 23 373 inmates entered the
NC DPS (Table); most were black men and more than half had
a prior incarceration. Of these 23 373 inmates, 22 134 (94.7%)
had HIV testing performed on blood remaining after syphilis
testing (Figure). Reasons for not having an HIV test included
no blood drawn, insufficient quantity, or lost specimen. Test-
ing of excess blood revealed 320 inmates (1.45%) to be HIV se-
ropositive. Of those who tested HIV seropositive, 300 (93.8%)
were known by the NC DHHS to be infected with HIV prior to
incarceration. Therefore, 20 of 22 134, or 0.09% (95% CI, 0.06%-
0.14%) of tested inmates were infected and not known to be
previously.
Among the 1239 entering inmates without HIV testing of
excess blood, 1066 underwent voluntary HIV testing by the
prison, 36 of whom (4.8%) were HIV seropositive. All 36 were
previously known by the NC DHHS to be infected with HIV.
Discussion | Although the overall prevalence of HIV infection
was high at 1.45%, the prevalence of undiagnosed infection
was 0.09% and the yield of screening of individuals entering
prison in North Carolina was low, with more than 93% of
infected inmates previously known by health authorities to
be infected. Therefore, in contrast to the perception that
undiagnosed HIV infection is prevalent among incarcerated
individuals, our results indicate that few new cases of HIV
enter prison. The confidence interval around the prevalence
of undiagnosed infection included 0.1%, the threshold
above which the US Centers for Disease Control and Preven-
Table. Characteristics of Inmates Entering Prison in North Carolina
No. (%) of Inmates
New to NC DPS
(n = 23 373)
HIV Test of Excess Blooda
Yes




Female 2657 (11.4) 2499 (11.3) 158 (12.8)
Male 20 701 (88.6) 19 620 (88.7) 1081 (87.3)
Missing 15 (<1) 15 (<1) 0
Raceb
White 9311 (39.84) 8844 (39.96) 467 (37.69)
Black 12 570 (53.78) 11 860 (53.58) 710 (57.30)
Native American 366 (1.57) 352 (1.59) 14 (1.13)
Asian 47 (0.20) 44 (0.20) 3 (0.24)
Otherc 934 (4.00) 899 (4.06) 35 (2.82)
Unknown 145 (0.62) 135 (0.61) 10 (0.81)
Prior incarceration
Yes 12 184 (52.1) 11 585 (52.3) 599 (48.4)
No 11 188 (47.9) 10 548 (47.7) 640 (51.7)
Missing 1 (<1) 1 (<1) 0
Abbreviations: HIV, human
immunodeficiency virus; NC DPS,
North Carolina Department of Public
Safety.
a None of the distributions of the
characteristics were significantly
different among inmates with a
study HIV test vs those without.
b Self-reported.
c Other included inmates who
identified as having mixed race.
2198 JAMA November 27, 2013 Volume 310, Number 20 jama.com
Copyright 2013 American Medical Association. All rights reserved.
tion recommends routine HIV screening in health care
settings.5 Other at-risk populations with higher levels of
undiagnosed HIV infection may constitute a higher priority
for screening for HIV than prisoners. Of all new HIV diagno-
ses in North Carolina in 2008-2009, less than 2% were
prison entrants.6
There are limitations to our study. Prior HIV testing may
have occurred as a consequence of screening during a previ-
ous incarceration, although almost half of the inmates with
known HIV infection had no history of incarceration. Addi-
tionally, some with a prior positive HIV test may not have re-
ceived their results and without screening upon incarcera-
tion would remain unaware of their HIV status. However,
according to the NC DHHS, 90% of those testing HIV seroposi-
tive in North Carolina in 2008-2009 were notified of their re-
sults. Furthermore, although North Carolina has the eighth
highest prevalence of HIV in the United States, these results
may not generalize to other states. In addition, the few cases
of previously unknown HIV coupled with limited available in-
mate data precluded analyses to identify prisoner character-
istics that could be used to enhance detection of undiag-
nosed HIV infection.
David Alain Wohl, MD
Carol Golin, MD
David L. Rosen, PhD, MD
Jeanine M. May, PhD
Becky L. White, MD
Author Affiliations: University of North Carolina, Chapel Hill (Wohl); Sheps
Center for Health Services Research, University of North Carolina, Chapel Hill
(Golin, May, White); Center for Infectious Diseases, University of North Carolina,
Chapel Hill (Rosen).
Corresponding Author: David Alain Wohl, MD, University of North Carolina,
130 Mason Farm Rd, Chapel Hill, NC 27599 (wohl@med.unc.edu).
Author Contributions: Dr Wohl had full access to all of the data in the study and
takes responsibility for the integrity of the data and the accuracy of the data
analysis.
Study concept and design: Wohl, Golin, Rosen, White.
Acquisition of data: Wohl, White.
Analysis and interpretation of data: Wohl, Golin, Rosen, May, White.
Drafting of the manuscript: Wohl, May, White.
Critical revision of the manuscript for important intellectual content: Wohl, Golin,
Rosen, White.
Statistical analysis: Wohl, Rosen, May.
Obtained funding: Wohl, Golin, Rosen.
Administrative, technical, or material support: Wohl, White.
Study supervision: Wohl, Golin, White.
Conflict of Interest Disclosures: The authors have completed and submitted
the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Wohl
reported serving as a consultant to Janssen and Gilead; and receiving grant
funding from Merck, GlaxoSmithKline, Gilead, and ViiV. Dr White reported
receiving payment for lectures from Gilead Sciences. No other disclosures were
reported.
Funding/Support: This research was supported by grant R01 MH079720-01A1
from the National Institute of Mental Health and grant AI 50410-04 from the
University of North Carolina Center for AIDS Research.
Role of the Sponsor: The National Institute of Mental Health and the University
of North Carolina Center for AIDS Research had no role in the design and
conduct of the study; collection, management, analysis, and interpretation of
the data; preparation, review, or approval of the manuscript; and decision to
submit the manuscript for publication.
Additional Contributions: We acknowledge the contributions of the following
co-investigators who assisted in study design and analysis: Andrew Kaplan, MD,
J. Michael Bowling, PhD, Peter Leone, MD, and Robert Devellis, PhD (all with the
University of North Carolina, Chapel Hill); Paula Smith, MD (North Carolina
Department of Public Safety [NC DPS]); and Rebecca Ochtera, PhD
(Kaiser-Permanente). We also acknowledge the University of North Carolina,
Chapel Hill, research staff: Kelly Green, MPH, Monique Williams, Dani Strauss,
Makisha Ruffin, and Catherine Grodensky, MPH. The NC DPS facility nurses and
administrators and the North Carolina Department of Health and Human
Services Communicable Disease Branch provided access and constructive
advice to the research team. Drs Bowling, Devellis, and Leone and Mss Green,
Williams, Strauss, and Ruffin received salary support from the National
Institutes of Health grant supporting the study. Drs Kaplan, Smith, and Ochtera
and Ms Grodensky did not receive compensation for their contributions.
1. Maruschak LM, Beavers R. HIV in prisons, 2007-08. http://bjs.ojp.usdoj.gov
/content/pub/pdf/hivp08.pdf. Accessibility verified October 31, 2013.
2. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM.
HIV/AIDS among inmates of and releasees from US correctional facilities, 2006:
declining share of epidemic but persistent public health opportunity. PLoS One.
2009;4(11):e7558.
3. Altice FL, Mostashari F, Selwyn PA, et al. Predictors of HIV infection among
newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol.
1998;18(5):444-453.
4. Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for
action ignored. Am J Public Health. 2003;93(5):759-763.
5. Branson BM, Handsfield HH, Lampe MA, et al; Centers for Disease Control
and Prevention (CDC). Revised recommendations for HIV testing of adults,
adolescents, and pregnant women in health-care settings. MMWR Recomm Rep.
2006;55(RR-14):1-17.
6. North Carolina Department of Health and Human Services Communicable
Disease Branch. 2008 HIV/STD surveillance report. http://epi.publichealth.nc
.gov/cd/stds/figures/std08rpt.pdf. Accessed January 30, 2013.
COMMENT & RESPONSE
Health Care Cost Control and Views of Physicians
To the Editor Dr Tilburt and colleagues1 presented a survey of
physicians’ views on controlling health care costs that sug-
gested physicians do not hold themselves primarily respon-
sible for decreasing costs. Instead, physicians look to many
others, including trial lawyers, health insurance companies,
pharmaceutical and medical device manufacturers, and
even patients. Dr Emanuel and Mr Steinmetz,2 in an accom-
Figure. Testing of Inmates Entering the North Carolina Prison System
for Human Immunodeficiency Virus (HIV)
320 Positive test result for HIV
300 Previously known to have HIV
20 New diagnosis of HIV
22 134 Had HIV test performed on blood remaining
from state-required syphilis test
23 373 Entrants to the North Carolina Department of Public
Safety from May 28, 2008, to April 15, 2009
21 814 Negative test result for HIV
1239 Excluded (did not have HIV test
performed on excess blood remaining
from state-required syphilis testing)a
a There were 1066 inmates who did not have HIV test performed on excess
blood remaining from state-required syphilis testing but who were tested for
HIV by the prison system. Of these, 36 tested positive for HIV and all were
previously known by the North Carolina Department of Health and Human
Services to be infected with HIV.
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